Search

everythinglearnresearchcommunity

for

Search:↓

Certain genetic variations in IL18 may increase the risk of alopecia areata in Koreans.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

HB-EGF boosts the hair growth ability of stem cells, making it a potential hair loss treatment.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Different types of cell death affect skin health and inflammation, and understanding them could improve treatments for skin diseases.

Certain IL-18 gene variations may increase the risk of alopecia areata.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Udenafil may help hair grow by activating certain stem cells.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Melatonin affects gene expression in goat hair follicles, potentially increasing cashmere production.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

A man with complete hair loss and ulcerative colitis regrew hair after treatment with azathioprine.

Hair dye ingredient PPD causes cell death and aging in human hair cells by altering microRNA levels.

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

A woman with rheumatoid arthritis lost all her hair during adalimumab treatment, and stopping the drug didn't help.

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.

Lung and liver macrophages protect our tissues and their dysfunction can cause various diseases.

Hair follicle stem cells change states with age, affecting hair growth and aging.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

Understanding hair growth involves complex factors, and more research is needed to improve treatments for hair loss conditions.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

New treatments focusing on immune pathways show promise for stubborn hair loss.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

Softer hydrogels help wounds heal better with less scarring.